96 related articles for article (PubMed ID: 15971886)
1. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
Ohta S; Ishimitsu T; Minami J; Ono H; Matsuoka H
Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
[TBL] [Abstract][Full Text] [Related]
4. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
Kamijo A; Sugaya T; Hikawa A; Okada M; Okumura F; Yamanouchi M; Honda A; Okabe M; Fujino T; Hirata Y; Omata M; Kaneko R; Fujii H; Fukamizu A; Kimura K
Am J Pathol; 2004 Oct; 165(4):1243-55. PubMed ID: 15466390
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of liver fatty acid-binding protein in health-check participants.
Ishimitsu T; Ohta S; Saito M; Teranishi M; Inada H; Yoshii M; Minami J; Ono H; Hikawa A; Shibata N; Sugaya T; Kamijo A; Kimura K; Ohrui M; Matsuoka H
Clin Exp Nephrol; 2005 Mar; 9(1):34-9. PubMed ID: 15830271
[TBL] [Abstract][Full Text] [Related]
7. [L-type fatty acid binding protein (L-FABP) and kidney disease].
Kamijo-Ikemori A; Sugaya T; Kimura K
Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
[TBL] [Abstract][Full Text] [Related]
8. Urinary liver type fatty acid binding protein in diabetic nephropathy.
Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
[TBL] [Abstract][Full Text] [Related]
9. Kidney injury biomarkers after cardiac angiography in children with congenital heart disease.
Nishida M; Kubo S; Morishita Y; Nishikawa K; Ikeda K; Itoi T; Hosoi H
Congenit Heart Dis; 2019 Nov; 14(6):1087-1093. PubMed ID: 31605509
[TBL] [Abstract][Full Text] [Related]
10. Quantification of L-type fatty acid binding protein in the urine of preterm neonates.
Tsukahara H; Sugaya T; Hayakawa K; Mori Y; Hiraoka M; Hata A; Mayumi M
Early Hum Dev; 2005 Jul; 81(7):643-6. PubMed ID: 15970406
[TBL] [Abstract][Full Text] [Related]
11. Urinary fatty acid binding protein in renal disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Clin Chim Acta; 2006 Dec; 374(1-2):1-7. PubMed ID: 16860300
[TBL] [Abstract][Full Text] [Related]
12. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
[TBL] [Abstract][Full Text] [Related]
13. Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?
Nakayama H; Echizen H; Gomi T; Shibuya Y; Nakamura Y; Nakano K; Arashi H; Itai T; Ohnishi S; Tanaka M; Orii T
Ther Drug Monit; 2009 Feb; 31(1):126-30. PubMed ID: 19125150
[TBL] [Abstract][Full Text] [Related]
14. [Contrast nephropathy with a non-ionic iodide medium in patients with normal and mildly impaired renal function].
Usutani S
Nihon Jinzo Gakkai Shi; 2000 May; 42(4):338-45. PubMed ID: 10897593
[TBL] [Abstract][Full Text] [Related]
15. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
[TBL] [Abstract][Full Text] [Related]
16. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Inoue T; Node K
Am J Nephrol; 2006; 26(1):82-6. PubMed ID: 16534182
[TBL] [Abstract][Full Text] [Related]
17. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
[TBL] [Abstract][Full Text] [Related]
18. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
Sasaki H; Kamijo-Ikemori A; Sugaya T; Yamashita K; Yokoyama T; Koike J; Sato T; Yasuda T; Kimura K
Nephron Clin Pract; 2009; 112(3):c148-56. PubMed ID: 19390215
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
Mou S; Wang Q; Li J; Shi B; Ni Z
Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
[TBL] [Abstract][Full Text] [Related]
20. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
